Skip to content

NIAID R01 Success Rate: FY2024 and FY2025 Data

Updated 9 official sources

Quick Answer: NIAID's own count puts its FY2024 R01-equivalent success rate at 15.8% (589 awards from 3,731 applications).

Full answer and how we checked it

NIH's Data Book shows NIAID at 14.5% in FY2025 (580 R01 and R37 awards from 3,992 applications), with brand-new R01s at 12.8%. NIAID no longer uses a score cutoff in FY2026. A Grantsights pull of NIH RePORTER found 754 competing NIAID R01 and R37 award records for FY2026, up from 563 in FY2025.

This guide is for: investigators with a scored or planned NIAID R01 or R21 who want the institute's real funding odds, how they moved from FY2020 to FY2025, and what FY2026 award records show before the official numbers arrive.

Data note: FY2020-FY2024 counts come from NIAID's December 18, 2024 Funding News tabulation. FY2025 rates come from NIH Data Book table 206 (data last updated February 18, 2026), where Grantsights summed the R01 and R37 rows for NIAID. FY2026 counts come from a Grantsights pull of the NIH RePORTER API on October 1, 2026 (administering institute NIAID, activity codes R01 and R37, award types 1 and 2, fiscal years 2024-2026). RePORTER counts awards, not applications.

In this guide

The NIH and NSF funding odds tracker shows the same Data Book R01 measures for every NIH institute, so you can see where NIAID ranks.

The searches behind this page ask one thing: what share of NIAID R01 applications get funded? The answer depends on which year, which count, and whether you mean new applications or renewals. This page lays the official numbers side by side and adds what the FY2026 award record shows.

According to NIAID's FY2024 application and award tabulation (opens in a new tab), the institute's FY2024 appropriation of $6,562,279,000 matched FY2023 exactly, the first flat year since 2015. Applications still rose, and the success rate fell about 1.5 percentage points.

From Manusights, our sister product

Applying for an R01 or R21? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a new R01 or R21, $199 for a resubmission. Back within 3 business days of your upload.

Order a grant review

NIAID R01 Success Rate by Fiscal Year, FY2020 to FY2025

The table below uses NIAID's own figures where they exist and NIH's Data Book for FY2025. Both define R01-equivalent as R01 plus R37.

Fiscal yearApplicationsCompeting awardsSuccess rateSource
FY20203,50380222.9%NIAID Funding News
FY20213,98163616.0%NIAID Funding News
FY20223,47357516.6%NIAID Funding News
FY20233,60962817.4%NIAID Funding News
FY20243,73158915.8%NIAID Funding News
FY20253,99258014.5%NIH Data Book table 206

NIAID wrote that its R01-equivalent rate "has not yet returned to levels typical before the pandemic, which were often slightly above 20 percent." FY2025 moved further from that mark. Applications reached 3,992 in the NIH count, the highest in the series, while awards stayed near 580.

For context across every research project grant, the NIH success-rate tables (opens in a new tab) show NIAID funding 1,202 of 7,792 RPG applications in FY2025 (15.4%), down from 18.3% in FY2024.

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

Why NIAID's Count and NIH's Count Differ

For FY2024, NIAID reported 3,731 applications and 589 awards. NIH's Data Book table 206 shows 3,654 applications and 593 awards for the same institute and codes. The gap is small, and it comes from counting rules: NIAID notes that "in other contexts, NIAID and others may include additional activity codes when tabulating R01-equivalent," and NIH's success-rate definition (opens in a new tab) counts multiple submissions of the same project in one fiscal year only once and credits jointly funded awards to the administering institute.

FY2024 measureNIAID Funding NewsNIH Data Book
R01-equivalent applications3,7313,654
R01-equivalent awards589593
Success rate15.8%16.2%

Use one source per comparison. Mixing NIAID's FY2024 rate with NIH's FY2025 rate overstates the drop by a few tenths of a point. That's not a big error, but it's an avoidable one when a department chair asks for a trend line.

New R01s Versus Renewals at NIAID

The headline rate hides a split that changes strategy. Renewals (Type 2) win far more often than new applications (Type 1), and both fell in FY2025.

NIAID R01 onlyFY2023FY2024FY2025
New applications reviewed3,2263,3173,613
New awards503470462
New success rate15.6%14.2%12.8%
Renewal applications reviewed297310353
Renewal awards989795
Renewal success rate33.0%31.3%26.9%

Source: NIH Data Book table 206. For example, NIAID received 3,613 new R01 applications in FY2025 and funded 462 of them, so a first-time applicant faced roughly one-in-eight odds. A PI renewing a productive award faced better than one-in-four. Grantsights analysis of the series shows the new-application rate has not topped 16% since FY2020, when it was 20.3%.

The practical read: if you hold an NIAID R01, the renewal is the most valuable application you'll write this cycle. Start it early enough to absorb one resubmission before the project period ends.

NIAID Paylines, FY2020 to FY2025, and Why FY2026 Has None

Until FY2025, NIAID published paylines. R01 paylines were percentiles for established investigators; R21 paylines were overall impact scores. According to NIAID, the new and early-stage investigator R01 payline was "usually 4 percentiles higher."

Fiscal yearR01 payline (percentile)R21 payline (impact score)
FY20201431
FY20211431
FY20221228
FY20231229
FY20241028
FY2025 interim823

For FY2026, the NIAID funding policy on grants.nih.gov (opens in a new tab) says the institute "will no longer use a score cutoff as the basis for funding." It weighs peer review alongside investigator status (new, early-stage, established, at-risk), portfolio balance and priorities. The policy adds that NIAID "aims to achieve a success rate for early stage and new investigators that meets or exceeds that of established investigators," and that single-project awards above $1 million in direct costs get additional levels of review.

NIAID's page on the NIH Unified Funding Strategy (opens in a new tab) describes the steps: study section scores, a standardized program officer assessment, then division and leadership review. The FY2026 policy page now also notes that NIH is operating under a continuing resolution that began October 1, 2026, so FY2027 terms may change.

Don't treat the old payline table as a current threshold. It's useful for one thing: showing how far the competitive bar moved before the cutoff disappeared. The NIH paylines guide covers the same shift at NIA and NHLBI.

NIAID R21 Success Rate: Not an Easier Door

Many investigators assume the R21 is the safer bet. NIAID's own numbers say otherwise.

Fiscal yearR21 applicationsR21 awardsR21 success rateR01-equivalent rate
FY20222,84540114.1%16.6%
FY20232,50553321.3%17.4%
FY20242,52440316.0%15.8%
FY2025 (NIH table)2,95542914.5%14.5%

FY2022-FY2024 figures are NIAID's; FY2025 is NIH Data Book table 206. NIAID itself told applicants that "the size and scope of your project," not a presumption about odds, should decide the mechanism. The R21 guide covers the combined $275,000 direct-cost limit over two years and the scope that make it a different project, not a smaller R01.

There's one more FY2025 change: NIH's table shows average NIAID R21 funding rising from $229,176 in FY2024 to $341,663 in FY2025. NIAID's FY2026 policy states that unsolicited domestic R21s and R03s are multi-year funded for the full project period, which loads more than one year of money into a single fiscal year.

FY2025 Award Dollars Rose While Award Counts Fell

NIH's table 206 shows NIAID's R01 and R37 funding climbing from $406.1 million in FY2024 to $623.2 million in FY2025, while awards slipped from 593 to 580. The average per award went from $684,765 to $1,074,467.

That isn't a sudden jump in project size. According to NIH's FY2025 by-the-numbers post (opens in a new tab), NIH-wide changes "were likely due in part to more awards being forward funded than previous years." Forward-funded (multi-year funded) awards pay several years up front from one year's appropriation.

Grantsights checked this in the award record. In RePORTER, an NIH multi-year funded award has one budget period that spans the project. Counting new NIAID R01 and R37 awards whose budget period runs longer than 13 months:

New NIAID R01/R37 awards (RePORTER)FY2024FY2025FY2026
New award records470464630
Multi-year funded (budget period over 13 months)18349
Median total award, single-year budgets$719,405$696,985$762,758
Median first-year direct cost, single-year budgets$482,232$467,945$498,952

Every dollar spent on a forward-funded award is a dollar not available for another new award that year, which is one reason FY2025 odds fell even though NIAID's total spending held up. NIH's FY2026 fiscal policy notice (opens in a new tab) caps FY2026 multi-year obligations at the FY2025 level, and NIAID's FY2026 count of multi-year funded new awards fell to 49.

What FY2026 Award Records Show So Far

NIH hasn't published FY2026 success rates. The award side is visible now. Grantsights pulled every FY2026 NIAID R01 and R37 competing award in RePORTER on October 1, 2026, the day after the fiscal year closed.

NIAID competing R01/R37 recordsFY2024FY2025FY2026
All competing (new plus renewal)575563754
New (Type 1)470464630
Competing renewal (Type 2)10599124

FY2026 brought about 190 more competing R01 awards than FY2025. That's a real funding trend in the award record, and it came in a year when, according to NIH, the appropriation rose 1% to $47.5 billion. It isn't yet a success rate. If FY2026 applications rose the way FY2025 applications did, the rate could improve less than the award count suggests. If NIH follows its FY2025 schedule, when table 206 updated in February, FY2026 rates should appear in early 2027.

Timing is also visible. FY2026 new NIAID R01 award notices clustered in August (129), June (106), July (99) and February (90). A strong score from the October or February council round can still turn into an award late in the fiscal year.

What NIAID's Success-Rate Tables Don't Tell You

SourceWhat it gives youWhat it leaves out
NIAID Funding News tabulationApplications, awards, rates and paylines by yearYour score's odds under the FY2026 no-cutoff policy
NIH Data Book table 206New versus renewal rates by instituteRates by study section, ESI status or percentile band
NIH RePORTEREvery award, its size and its notice dateUnfunded applications, so no rate on its own
NIAID FY2026 policy pageDecision factors and review thresholdsHow factors are weighed against each other

The common mistake is reading the institute-wide rate as a personal probability. A 12.8% new-application rate covers triaged applications that never had a chance alongside top-decile scores. Your percentile, ESI status and program fit matter more than the average.

Resubmit, Switch Mechanisms, or Wait

Use the numbers to choose a next step, not to predict a single application.

Your situationBest next actionWhy the data supports it
New R01 scored but unfundedAsk the program officer if it's still under consideration, then prepare the A1New-application odds were 12.8% in FY2025, so most strong applications need a resubmission
Renewal due within 18 monthsSubmit early enough to allow one resubmissionRenewals succeeded at 26.9% in FY2025, more than double new applications
Considering an R21 for better oddsSkip that reasoning; choose by scopeNIAID's R21 and R01-equivalent rates were equal in FY2025
ESI applicantConfirm ESI status in eRA Commons before reviewNIAID's FY2026 policy targets ESI rates at or above established investigators
Budget above $1 million direct in any yearTalk to NIAID staff before submittingSuch applications get extra review layers

The summary statement guide and the resubmission guide cover the A1 work. For NIH-wide context, compare these figures with the R01 success-rate data page, and for other institutes see the NHLBI payline page and NCI payline page. Searching for a different NIH route? Start with Grantsights grant search.

Sources

Download this page's tables (CSV). When you use the numbers, credit Grantsights and the source named on the page; see how to cite.

More award history and success-rate data

Who won, how many awards were made, and success rates, from public award records and agency tables.

NIH

USDA NIFA

SBIR

Frequently Asked Questions

What was the NIAID R01 success rate in FY2024?

NIAID reported a 15.8% success rate for R01-equivalent applications (R01 plus R37) in FY2024: 589 competing awards from 3,731 applications. NIH's Data Book, which counts slightly differently, shows 593 awards from 3,654 applications, or 16.2%.

What was the NIAID R01 success rate in FY2025?

NIAID had not published its own FY2025 tabulation when Grantsights checked on October 1, 2026. NIH Data Book table 206, updated February 18, 2026, shows 580 R01 and R37 awards from 3,992 NIAID applications in FY2025, a 14.5% success rate. New R01s alone were funded at 12.8%.

Does NIAID still have a payline?

No. NIAID's FY2026 funding policy says it will no longer use a score cutoff as the basis for funding. Peer review still matters, but NIAID also weighs investigator status, portfolio balance and priorities. The last published R01 payline for established investigators was an interim 8th percentile for FY2025.

Is an NIAID R21 easier to get than an R01?

Not reliably. NIAID's own figures show R21 success rates of 16.0% in FY2024 against 15.8% for R01-equivalents, and NIH's FY2025 table shows 14.5% for both. NIAID itself advises choosing the activity code by project size and scope rather than perceived odds.

How many R01s did NIAID fund in FY2026?

Final FY2026 success rates are not out yet. A Grantsights pull of NIH RePORTER on October 1, 2026 found 754 competing NIAID R01 and R37 award records for FY2026, including 630 new awards, against 563 and 464 in FY2025. Award records are not applications, so this is not a success rate.

Last updated October 1, 2026. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.